Variables | 1:GnRH-a-HRT | 2:HRT | 3:OI | 4:NC | P value | ||
---|---|---|---|---|---|---|---|
No. of cases | 451 | 696 | 42 | 859 | - | ||
Maternal age at FET, years | 32.29āĀ±ā3.49 | 32.11āĀ±ā3.53 | 32.71āĀ±ā3.49 | 32.29āĀ±ā3.40 | 0.551 | ||
Duration of infertility, years | 3.50āĀ±ā2.34 | 4.02āĀ±ā2.67 | 3.74āĀ±ā2.36 | 4.12āĀ±ā2.68 | 0.001a | ||
Body mass index, kg/m2 | 20.75āĀ±ā2.45 | 20.80āĀ±ā2.48 | 21.25āĀ±ā2.83 | 20.69āĀ±ā2.42 | 0.607 | ||
Infertility diagnosis | Primary infertility, n (%) | 61.2% (276/451) | 54.7% (381/696) | 40.5% (17/42) | 59.4% (510/859) | 0.001a | |
Secondary infertility, n (%) | 36.1%(163/451) | 43.5%(303/696) | 54.8%(23/42) | 40%(344/859) | |||
Infertility-freeb | 2.7%(12/451) | 1.7%(12/696) | 4.8%(2/42) | 0.6%(5/859) | |||
Infertility etiology, n (%) | Tubal factor | 51.2%(231/451) | 56.8%(395/696) | 61.9%(26/42) | 63.7%(547/859) | 0.000a | |
Male factor | 49.7%(224/451) | 47.6%(331/696) | 57.1%(24/42) | 47.4%(407/859) | 0.556 | ||
Other | 33.9%(153/451) | 35.5%(247/696) | 19%(8/42) | 24.9%(214/859) | 0.000a | ||
endometriosis ASRM stagec | ASRMI-II | 14.6%(66/451) | 45.7%(318/696) | 50%(21/42) | 51.2%(440/859) | 0.000a | |
ASRMIII-IV | 85.4%(385/451) | 54.3%(378/696) | 50%(21/42) | 48.8%(419/859) | |||
endometriosis complicated with adenomyosis | 20.4%(92/451) | 3.6%(25/696) | 14.3%(6/42) | 3.3%(28/859) | 0.000a | ||
Ovarian stimulation protocols, n (%) | Long GnRH-a | 55.2%(249/451) | 74.1%(516/696) | 69%(29/42) | 79.6%(684/859) | 0.000a | |
GnRH-a ultra-long | 12.4%(56/451) | 4%(28/696) | 0%(0/42) | 2.1%(18/859) | |||
GnRH antagonist | 24.8%(112/451) | 15.1%(105/696) | 26.2%(11/42) | 12.2%(105/859) | |||
Other protocols | 7.5%(34/451) | 6.8%(47/696) | 4.8%(2/42) | 6.1%(52/859) | |||
Gonadotropin dose, IU | 2621āĀ±ā945 | 2325āĀ±ā894 | 2748āĀ±ā1038 | 2300āĀ±ā848 | 0.000a | ||
No. of oocytes retrieved | 12.15āĀ±ā7.53 | 15.09āĀ±ā8.9 | 14.5āĀ±ā9.35 | 15.29āĀ±ā8.43 | 0.000a | ||
Blastocyst formation rate | 0.60āĀ±ā0.28 | 0.56āĀ±ā0.28 | 0.59āĀ±ā0.28 | 0.56āĀ±ā0.29 | 0.313 | ||
Type of embryo transferred, n (%) | Cleavage embryo | 45.0%(203/451) | 42.1%(293/696) | 35.7%(15/42) | 45.5%(391/859) | 0.365 | |
Blastocyst | 55.0%(248/451) | 57.9%(403/696) | 64.3%(27/42) | 54.5%(468/859) | |||
No. of embryos transferred | 1.58āĀ±ā0.57 | 1.71āĀ±ā0.65 | 1.48āĀ±ā0.51 | 1.78āĀ±ā0.68 | 0.000a | ||
No. of good quality embryos transferred | 1.15āĀ±ā0.69 | 1.13āĀ±ā0.78 | 0.93āĀ±ā0.75 | 1.12āĀ±ā0.78 | 0.287 | ||
Rate of good quality embryos transferred | 83.8%(378/451) | 78.3%(545/696) | 69%(29/42) | 78.9%(678/859) | 0.033a | ||
Clinical Pregnancy | 53.2%(240/451) | 49.7%(346/696) | 54.8%(23/42) | 46.8%(402/859) | 0.141 | ||
Live Birth | 43.5%(196/451) | 39.8%(277/696) | 45.2%(19/42) | 39.0%(335/859) | 0.397 | ||
Early Miscarriage | 15.4%(37/240) | 18.2%(63/346) | 17.4%(4/23) | 15.4%(62/402) | 0.732 |